Skip to main content

Table 1 Demographic, clinical, and CSF data of the analyzed patients

From: Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis

 

Female/male (ratio)

Age, median (range)

EDSS, median (range)

Time since diagnosis, median (range)

Patients in clinical relapse, n (%)

Patients with Gd+ lesions on MRI, n (%)

Number of cells/μl CSF, median (range)

IgG index, median (range)

Relapsing remitting MS (n = 31)

20/11 (1.8)

33 years (20–65)

1 (0–4.5)

12 months (0.1–144)

12 (38.7)

13 (41.9)

7 (0.5–45)

0.81 (0.43–2.2)